CompoAtlas

VisuMix M

Natural health product licensed in Canada

Other names
Viszen-M
Licence holder
Elan Healthcare Inc.
NPN or DIN-HM
80110095
Status
Active licence
Licence date
25 May 2021
Revision date
3 October 2023
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Extrait de pépins de raisin

Source : Vitis vinifera - Graine

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 250 mg

Potency : 40 % Proanthocyanidins

25 mgNot calculated
(3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol

Source : Lutéine

10 mgNot calculated
Vitamine E

Source : Succinate d'acide de d-alpha tocophéryle

30 UINot calculated
Vitamine E

Source : Succinate d'acide de d-alpha tocophéryle

20 mg ATNot calculated
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : Zeaxanthin

2 mgNot calculated
2-(3,4-dihydroxyphényl)-3,5,7-trihydroxychromen-4-one

Source : Quercétine

20 mgNot calculated
Cuivre1 mg2,000 µg
L-Glutathione

Source : Glutathione

50 mgNot calculated
Vaccinium myrtillus

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 800 mg

Potency : 25 % Anthocyanins

80 mgNot calculated
Vitamine C

Source : Acide ascorbique

100 mg200,000 µg
Zinc

Source : Oxyde de zinc

10 mg20,000 µg

Non-medicinal ingredients

Dioxyde de silicium, Hypromellose, Stéarate de magnésium, Cellulose microcristalline, Phosphate de calcium, dibasique, dihydraté

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Source of/Provides antioxidants for the maintenance of eye health. Source of/Provides antioxidants. Helps to maintain/support eyesight in certain conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to maintain eyesight and in the development and maintenance of night vision. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80110095

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line